Progenics Pharmaceuticals Inc. Return on Tangible Equity 2010-2020 | PGNX

Current and historical return on tangible equity values for Progenics Pharmaceuticals Inc. (PGNX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2020-03-31 $-0.07B $0.01B -250.47%
2019-12-31 $-0.07B $0.02B -173.58%
2019-09-30 $-0.07B $0.03B -133.94%
2019-06-30 $-0.08B $0.05B -110.64%
2019-03-31 $-0.07B $0.06B -115.42%
2018-12-31 $-0.07B $0.08B -126.42%
2018-09-30 $-0.06B $0.10B -145.70%
2018-06-30 $-0.05B $0.02B -252.05%
2018-03-31 $-0.05B $0.02B -225.88%
2017-12-31 $-0.05B $0.02B -178.95%
2017-09-30 $-0.06B $0.02B -141.94%
2017-06-30 $-0.00B $0.03B -7.80%
2017-03-31 $0.01B $0.05B 13.73%
2016-12-31 $0.01B $0.06B 20.73%
2016-09-30 $0.01B $0.07B 22.35%
2016-06-30 $-0.04B $0.03B -83.72%
2016-03-31 $-0.04B $0.04B -79.62%
2015-12-31 $-0.04B $0.05B -61.18%
2015-09-30 $-0.04B $0.06B -59.26%
2015-06-30 $0.00B $0.07B 3.59%
2015-03-31 $0.00B $0.08B 4.94%
2014-12-31 $0.01B $0.09B 6.37%
2014-09-30 $0.01B $0.10B 12.08%
2014-06-30 $-0.04B $0.06B -74.42%
2014-03-31 $-0.04B $0.07B -79.23%
2013-12-31 $-0.04B $0.04B -104.24%
2013-09-30 $-0.03B $0.05B -70.83%
2013-06-30 $-0.03B $0.05B -72.34%
2013-03-31 $-0.03B $0.03B -69.47%
2012-12-31 $-0.04B $0.07B -62.50%
2012-09-30 $-0.05B $0.04B -80.35%
2012-06-30 $-0.05B $0.05B -69.17%
2012-03-31 $0.02B $0.06B 26.49%
2011-12-31 $0.01B $0.07B 14.71%
2011-09-30 $0.00B $0.08B 3.19%
2011-06-30 $-0.00B $0.09B -6.72%
2011-03-31 $-0.07B $0.03B -128.70%
2010-12-31 $-0.07B $0.05B -95.89%
2010-09-30 $-0.05B $0.07B -59.60%
2010-06-30 $-0.05B $0.08B -49.74%
2010-03-31 $-0.05B $0.09B -45.93%
2009-12-31 $-0.03B $0.11B -27.68%